120 related articles for article (PubMed ID: 22197641)
1. Antiproliferative and iron chelating efficiency of the new bis-8-hydroxyquinoline benzylamine chelator S1 in hepatocyte cultures.
Lescoat G; Léonce S; Pierré A; Gouffier L; Gaboriau F
Chem Biol Interact; 2012 Jan; 195(2):165-72. PubMed ID: 22197641
[TBL] [Abstract][Full Text] [Related]
2. The new orally active iron chelator ICL670A exhibits a higher antiproliferative effect in human hepatocyte cultures than O-trensox.
Chantrel-Groussard K; Gaboriau F; Pasdeloup N; Havouis R; Nick H; Pierre JL; Brissot P; Lescoat G
Eur J Pharmacol; 2006 Jul; 541(3):129-37. PubMed ID: 16765341
[TBL] [Abstract][Full Text] [Related]
3. Modulation of cell proliferation and polyamine metabolism in rat liver cell cultures by the iron chelator O-trensox.
Gaboriau F; Laupen-Chassay C; Pasdeloup N; Pierre JL; Brissot P; Lescoat G
Biometals; 2006 Dec; 19(6):623-32. PubMed ID: 16944279
[TBL] [Abstract][Full Text] [Related]
4. Iron mobilization, cytoprotection, and inhibition of cell proliferation in normal and transformed rat hepatocyte cultures by the hydroxypyridinone CP411, compared to CP20: a biological and physicochemical study.
Gaboriau F; Chantrel-Groussard K; Rakba N; Loyer P; Pasdeloup N; Hider RC; Brissot P; Lescoat G
Biochem Pharmacol; 2004 Apr; 67(8):1479-87. PubMed ID: 15041465
[TBL] [Abstract][Full Text] [Related]
5. Hydroxyquinolines as iron chelators.
Pierre JL; Baret P; Serratrice G
Curr Med Chem; 2003 Jun; 10(12):1077-84. PubMed ID: 12678678
[TBL] [Abstract][Full Text] [Related]
6. Iron mobilisation and cellular protection by a new synthetic chelator O-Trensox.
Rakba N; Aouad F; Henry C; Caris C; Morel I; Baret P; Pierre JL; Brissot P; Ward RJ; Lescoat G; Crichton RR
Biochem Pharmacol; 1998 Jun; 55(11):1797-806. PubMed ID: 9714298
[TBL] [Abstract][Full Text] [Related]
7. New 8-hydroxyquinoline and catecholate iron chelators: influence of their partition coefficient on their biological activity.
Henry C; Rakba N; Imbert D; Thomas F; Baret P; Serratrice G; Gaude D; Pierre JL; Ward RJ; Crichton RR; Lescoat G
Biochem Pharmacol; 2001 Nov; 62(10):1355-62. PubMed ID: 11709195
[TBL] [Abstract][Full Text] [Related]
8. Antiproliferative and apoptotic effects of O-Trensox, a new synthetic iron chelator, on differentiated human hepatoma cell lines.
Rakba N; Loyer P; Gilot D; Delcros JG; Glaise D; Baret P; Pierre JL; Brissot P; Lescoat G
Carcinogenesis; 2000 May; 21(5):943-51. PubMed ID: 10783316
[TBL] [Abstract][Full Text] [Related]
9. Metabolization of iron by plant cells using O-Trensox, a high-affinity abiotic iron-chelating agent.
Caris C; Baret P; Beguin C; Serratrice G; Pierre JL; Laulhère JP
Biochem J; 1995 Dec; 312 ( Pt 3)(Pt 3):879-85. PubMed ID: 8554534
[TBL] [Abstract][Full Text] [Related]
10. Effects of deferasirox and deferiprone on cellular iron load in the human hepatoma cell line HepaRG.
Gaboriau F; Leray AM; Ropert M; Gouffier L; Cannie I; Troadec MB; Loréal O; Brissot P; Lescoat G
Biometals; 2010 Apr; 23(2):231-45. PubMed ID: 19997770
[TBL] [Abstract][Full Text] [Related]
11. Design of iron chelators: syntheses and iron (III) complexing abilities of tripodal tris-bidentate ligands.
d'Hardemare Adu M; Torelli S; Serratrice G; Pierre JL
Biometals; 2006 Aug; 19(4):349-66. PubMed ID: 16841245
[TBL] [Abstract][Full Text] [Related]
12. Antiproliferative effect on HepaRG cell cultures of new calix[4]arenes.
Rouge P; Pires VS; Gaboriau F; Dassonville-Klimpt A; Guillon J; Nascimento SD; Leger JM; Lescoat G; Sonnet P
J Enzyme Inhib Med Chem; 2010 Apr; 25(2):216-27. PubMed ID: 19883235
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological properties of iron chelators based on a bis-2-(2-hydroxy-phenyl)-thiazole-4-carboxamide or -thiocarboxamide (BHPTC) scaffold.
Rodriguez-Lucena D; Gaboriau F; Rivault F; Schalk IJ; Lescoat G; Mislin GL
Bioorg Med Chem; 2010 Jan; 18(2):689-95. PubMed ID: 20036563
[TBL] [Abstract][Full Text] [Related]
14. Examination of the antiproliferative activity of iron chelators: multiple cellular targets and the different mechanism of action of triapine compared with desferrioxamine and the potent pyridoxal isonicotinoyl hydrazone analogue 311.
Chaston TB; Lovejoy DB; Watts RN; Richardson DR
Clin Cancer Res; 2003 Jan; 9(1):402-14. PubMed ID: 12538494
[TBL] [Abstract][Full Text] [Related]
15. The effect of an iron (III) chelator, silybin, on the proliferation and cell cycle of Jurkat cells: a comparison with desferrioxamine.
Gharagozloo M; Khoshdel Z; Amirghofran Z
Eur J Pharmacol; 2008 Jul; 589(1-3):1-7. PubMed ID: 18619590
[TBL] [Abstract][Full Text] [Related]
16. Ethanol effect on cell proliferation in the human hepatoma HepaRG cell line: relationship with iron metabolism.
Tuoi Do TH; Gaboriau F; Ropert M; Moirand R; Cannie I; Brissot P; Loréal O; Lescoat G
Alcohol Clin Exp Res; 2011 Mar; 35(3):408-19. PubMed ID: 21143242
[TBL] [Abstract][Full Text] [Related]
17. Antiproliferative and apoptotic effects in rat and human hepatoma cell cultures of the orally active iron chelator ICL670 compared to CP20: a possible relationship with polyamine metabolism.
Lescoat G; Chantrel-Groussard K; Pasdeloup N; Nick H; Brissot P; Gaboriau F
Cell Prolif; 2007 Oct; 40(5):755-67. PubMed ID: 17877614
[TBL] [Abstract][Full Text] [Related]
18. Antiproliferative effect on HepaRG cell cultures of new calix[4]arenes. Part II.
Latxague L; Gaboriau F; Chassande O; Leger JM; Pires V; Rouge P; Dassonville-Klimpt A; Fardeau S; Jarry C; Lescoat G; Guillon J; Sonnet P
J Enzyme Inhib Med Chem; 2011 Apr; 26(2):204-15. PubMed ID: 20545489
[TBL] [Abstract][Full Text] [Related]
19. Comparative studies on the iron chelators O-TRENSOX and TRENCAMS: selectivity of the complexation towards other biologically relevant metal ions and Al(3+).
Biaso F; Baret P; Pierre JL; Serratrice G
J Inorg Biochem; 2002 Apr; 89(1-2):123-30. PubMed ID: 11931972
[TBL] [Abstract][Full Text] [Related]
20. Antiproliferative activity and therapeutic implications of potassium tris(4-methyl-1-pyrazolyl) borohydride in hepatocellular carcinoma.
Jin H; Xu Z; Li D; Huang J
Chem Biol Interact; 2014 Apr; 213():69-76. PubMed ID: 24412237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
